Polymorphisms in the CD28/CTLA4/ICOS genes: Role in malignant melanoma susceptibility and prognosis?

Cancer Immunology, Immunotherapy

Volumn 59, Issue 2, 2010, Pages 303-312

  Bouwhuis, Marna G ^a   Gast, Andreas ^b,d   Figl, Adina ^b   Eggermont, Alexander M M ^a   Hemminki, Kari ^b   Schadendorf, Dirk ^c   Kumar, Rajiv ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

CD28 CTLA4 ICOS; Melanoma; Polymorphism; Prognosis; Susceptibility

Indexed keywords

CD28 ANTIGEN; CELL ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INDUCIBLE COSTIMULATOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER RISK; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERMANY; HUMANS; MALE; MELANOMA; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; SKIN NEOPLASMS;

EID: 71849109946     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-009-0751-2     Document Type: Article

References (25)

1. H Uchi R Stan MJ Turk ME Engelhorn GA Rizzuto SM Goldberg JD Wolchok AN Houghton 2006 Unraveling the complex relationship between cancer immunity and autoimmunity: lessons from melanoma and vitiligo Adv Immunol 90 215 241 10.1016/S0065-2776(06)90006-6 1:CAS:528:DC%2BD1cXhsVCjurk%3D 16730265 (Pubitemid 43765798)
2. MB Atkins JW Mier DR Parkinson JA Gould EM Berkman MM Kaplan 1988 Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells N Engl J Med 318 1557 1563 1:STN:280:DyaL1c3jt1yjtA%3D%3D 3259674
3. GQ Phan P Attia SM Steinberg DE White SA Rosenberg 2001 Factors associated with response to high-dose interleukin-2 in patients with metastatic melanoma J Clin Oncol 19 3477 3482 1:CAS:528:DC%2BD3MXmtlGhurk%3D 11481353
4. H Gogas J Ioannovich U Dafni C Stavropoulou-Giokas K Frangia D Tsoutsos P Panagiotou A Polyzos O Papadopoulos A Stratigos, et al. 2006 Prognostic significance of autoimmunity during treatment of melanoma with interferon N Engl J Med 354 709 718 10.1056/NEJMoa053007 1:CAS:528:DC%2BD28XhsVWrsrw%3D 16481638 (Pubitemid 43247141)
5. MG Bouwhuis S Suciu S Collette S Aamdal WH Kruit L Bastholt U Stierner F Sales P Patel CJ Punt, et al. 2009 Autoimmune antibodies and recurrence-free interval in melanoma patients treated with adjuvant interferon J Natl Cancer Inst 101 869 877 10.1093/jnci/djp132 1:CAS:528:DC%2BD1MXnslKjtbY%3D 19509353
6. WA Teft MG Kirchhof J Madrenas 2006 A molecular perspective of CTLA-4 function Annu Rev Immunol 24 65 97 10.1146/annurev.immunol.24.021605.090535 1:CAS:528:DC%2BD28XkvFSqt78%3D 16551244
7. RJ Greenwald GJ Freeman AH Sharpe 2005 The B7 family revisited Annu Rev Immunol 23 515 548 10.1146/annurev.immunol.23.021704.115611 15771580 (Pubitemid 40563179)
8. LJ Appleman A Berezovskaya I Grass VA Boussiotis 2000 CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression J Immunol 164 144 151 1:CAS:528:DC%2BD3cXisVyh 10605005
9. H Ueda JM Howson L Esposito J Heward H Snook G Chamberlain DB Rainbow KM Hunter AN Smith G Di Genova, et al. 2003 Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease Nature 423 506 511 10.1038/nature01621 1:CAS:528:DC%2BD3sXktVygtLk%3D 12724780 (Pubitemid 36648570)
10. SS Amundsen AT Naluai H Ascher J Ek AH Gudjonsdottir J Wahlstrom BA Lie LM Sollid 2004 Genetic analysis of the CD28/CTLA4/ICOS (CELIAC3) region in coeliac disease Tissue Antigens 64 593 599 10.1111/j.1399-0039.2004.00312.x 1:CAS:528:DC%2BD2cXhtVKjsrbL 15496203 (Pubitemid 39472925)
11. JM Cozar JM Romero N Aptsiauri F Vazquez JR Vilchez M Tallada F Garrido F Ruiz-Cabello 2007 High incidence of CTLA-4 AA (CT60) polymorphism in renal cell cancer Hum Immunol 68 698 704 10.1016/j.humimm.2007.05.002 1:CAS:528: DC%2BD2sXosF2ru7s%3D 17678726 (Pubitemid 47126657)
12. N Erfani M Razmkhah AR Talei AM Pezeshki M Doroudchi A Monabati A Ghaderi 2006 Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer Cancer Genet Cytogenet 165 114 120 10.1016/j.cancergencyto.2005.07.020 1:CAS:528:DC%2BD28Xit1aqsL8%3D 16527605 (Pubitemid 43343504)
13. CM Balch AC Buzaid SJ Soong MB Atkins N Cascinelli DG Coit ID Fleming JE Gershenwald A Houghton Jr JM Kirkwood, et al. 2001 Final version of the American Joint Committee on cancer staging system for cutaneous melanoma J Clin Oncol 19 3635 3648 1:STN:280:DC%2BD3MvlvV2ktQ%3D%3D 11504745
14. T Ramirez-Montagut MJ Turk JD Wolchok JA Guevara-Patino AN Houghton 2003 Immunity to melanoma: unraveling the relation of tumor immunity and autoimmunity Oncogene 22 3180 3187 10.1038/sj.onc.1206462 1:CAS:528:DC%2BD3sXkt12qu78%3D 12789294 (Pubitemid 36713770)
15. Gogas H, Metaxas Y, Dafni U, Polyzos A, Fountzilas G, Pectasides E, Skarlos D, Tsoutsos D, Panagiotou P, Spyropoulou-Vlachou M et al (2008) Evaluation of CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon. J Clin Oncol 26: Suppl; abstr 9054
16. T Sun Y Zhou M Yang Z Hu W Tan X Han Y Shi J Yao Y Guo D Yu, et al. 2008 Functional genetic variations in cytotoxic T-lymphocyte antigen 4 and susceptibility to multiple types of cancer Cancer Res 68 7025 7034 10.1158/0008-5472.CAN-08-0806 1:CAS:528:DC%2BD1cXhtVCrs7rL 18757416
17. G Magistrelli P Jeannin N Herbault A Benoit De Coignac JF Gauchat JY Bonnefoy Y Delneste 1999 A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells Eur J Immunol 29 3596 3602 10.1002/(SICI)1521-4141(199911)29:11<3596::AID-IMMU3596>3.0.CO;2-Y 1:CAS:528:DyaK1MXnt1OgtLY%3D 10556814 (Pubitemid 29527807)
18. S Anjos A Nguyen H Ounissi-Benkalha MC Tessier C Polychronakos 2002 A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele J Biol Chem 277 46478 46486 10.1074/jbc.M206894200 1:CAS:528:DC%2BD38XovFKhurw%3D 12244107 (Pubitemid 35417644)
19. G Piras M Monne A Uras A Palmas M Murineddu L Arru A Bianchi A Calvisi L Curreli E Gaviano, et al. 2005 Genetic analysis of the 2q33 region containing CD28-CTLA4-ICOS genes: association with non-Hodgkin's lymphoma Br J Haematol 129 784 790 10.1111/j.1365-2141.2005.05525.x 1:CAS:528:DC%2BD2MXms1ehsL0%3D 15953005 (Pubitemid 40904529)
20. TY Cheng JT Lin LT Chen CT Shun HP Wang MT Lin TE Wang AL Cheng MS Wu 2006 Association of T-cell regulatory gene polymorphisms with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma J Clin Oncol 24 3483 3489 10.1200/JCO.2005.05.5434 1:CAS:528:DC%2BD28Xot1KisLk%3D 16849765 (Pubitemid 46638907)
21. XB Wang X Zhao R Giscombe AK Lefvert 2002 A CTLA-4 gene polymorphism at position -318 in the promoter region affects the expression of protein Genes Immun 3 233 234 10.1038/sj.gene.6363869 12058260 (Pubitemid 38961137)
22. K Suwalska E Pawlak L Karabon A Tomkiewicz T Dobosz D Urbaniak-Kujda K Kuliczkowski D Wolowiec A Jedynak I Frydecka 2008 Association studies of CTLA-4, CD28, and ICOS gene polymorphisms with B-cell chronic lymphocytic leukemia in the Polish population Hum Immunol 69 193 201 10.1016/j.humimm.2008.01.014 1:CAS:528:DC%2BD1cXktlWqs7Y%3D 18396212
23. F Dilmec A Ozgonul A Uzunkoy F Akkafa 2008 Investigation of CTLA-4 and CD28 gene polymorphisms in a group of Turkish patients with colorectal cancer Int J Immunogenet 35 317 321 10.1111/j.1744-313X.2008.00782.x 1:CAS:528:DC%2BD1cXht1Gmtr7J 18680513
24. A Heinzmann C Plesnar J Kuehr J Forster KA Deichmann 2000 Common polymorphisms in the CTLA-4 and CD28 genes at 2q33 are not associated with asthma or atopy Eur J Immunogenet 27 57 61 10.1046/j.1365-2370.2000.00198.x 1:CAS:528:DC%2BD3cXjsFCrtLs%3D 10792419 (Pubitemid 30213948)
25. WB Breunis E Tarazona-Santos R Chen M Kiley SA Rosenberg SJ Chanock 2008 Influence of cytotoxic T lymphocyte-associated antigen 4 (CTLA4) common polymorphisms on outcome in treatment of melanoma patients with CTLA-4 blockade J Immunother 31 586 590 10.1097/CJI.0b013e31817fd8f3 1:CAS:528: DC%2BD1cXnslKjt7w%3D 18528295